Ovarian

Adrenal Gland/Adrenocortical Basket Trials (Multiple Types) Biliary Tract/Gall Bladder/Cholangiocarcinoma (GI) Bladder/Urothelial (GU) Bone Metastases Brain and Central Nervous System (CNS) Breast Cervical (GYN) Colon/Rectal/Anal (GI) Endocrine Cancers Endocrine Neoplasia Esophageal (GI) Gastric/Stomach (GI) Gastrointestinal (GI) (Multiple Types) General Solid Tumors (Multiple Types) GenitoUrinary (GU) (Multiple Types) GEP-NET (NEC) GI Stromal Tumor (GIST) Gynecologic (GYN) (Multiple Types) Head and Neck Cancers Hepatocellular/Liver (GI) Hodgkins Lymphoma Insulinoma Kidney/Renal Cell Carcinoma (GU) Leukemias Lung Lymphomas Melanoma/Skin Cancers Mesothelioma Multiple Myeloma NeuroBlastoma NeuroEndocrine (NEC) (Multiple Types) NeuroEndocrine Carcinoma (NEC) Osteosarcoma Ovarian Ovarian/Primary Peritoneal (GYN) Pancreatic (GI) Paraganglioma (NEC) Penile (GU) Pheochromocytoma (NEC) Prostate (GU) Salivary Gland Sarcoma Synovial Carcinoma Testicular (GU) Thymoma Thyroid Unknown Primary Cancers Uterine (GYN) Vulvar (GYN)

Last Updated: Wed Jul 17 2024

Study Status

Enrolling

On Hold

Not Enrolling

Unknown

NCT05856409

Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence

This is a prospective study to investigate the potential efficacy of 68Ga-FAPI PET/CT for recurrence detection of epithelial ovarian cancer in comparison with 18F-FDG PET/CT.

🇺🇸

NCT06503146

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

Fibroblast-activation protein (FAP) is an enzyme that appears in high numbers in certain cancer cells. [18F]FAPI-74 is a new tracer-a substance that is injected into a person s body before an imaging scan. Researchers believe that [18F]FAPI-74 may be able to highlight FAP enzymes more effectively than approved tracers. If so, the new tracer would make it easier to find FAP-positive tumors in the body.